Literature DB >> 26973399

Predicting liver metastasis of gastrointestinal tract cancer by diffusion-weighted imaging of apparent diffusion coefficient values.

De-Xian Zheng1, Shu-Chun Meng1, Qing-Jun Liu1, Chuan-Ting Li1, Xi-Dan Shang1, Yu-Seng Zhu1, Tian-Jun Bai1, Shi-Ming Xu1.   

Abstract

AIM: To determine if efficacy of chemotherapy on liver metastasis of gastrointestinal tract cancer can be predicted by apparent diffusion coefficient (ADC) values of diffusion-weighted imaging (DWI).
METHODS: In total, 86 patients with liver metastasis of gastrointestinal tract cancer (156 metastatic lesions) diagnosed in our hospital were included in this study. The maximum diameters of these tumors were compared with each other before treatment, 2 wk after treatment, and 12 wk after treatment. Selected patients were classified as the effective group and the ineffective group, depending on the maximum diameter of the tumor after 12 wk of treatment; and the ADC values at different treatment times between the two groups were compared. Spearman rank correlation was used to analyze the relationship between ADC value and tumor diameter. Receiver operating characteristic curve (ROC curve) was used to analyze the ADC values before treatment to predict the patient's sensitivity and specificity degree of efficacy to the chemotherapy.
RESULTS: There was no difference in age between the two groups and in maximum tumor diameter before treatment and 2 wk after treatment. However, after 12 wk of treatment, maximum tumor diameter in the effective group was significantly lower than that in the ineffective group (P < 0.05). Before treatment, ADC values in the ineffective group were significantly higher than those in the effective group (P < 0.05). There was no difference in ADC values between the effective and ineffective groups after 2 and 12 wk of treatment. However, ADC values were significantly higher after 2 and 12 wk of treatment compared to before treatment in the effective group (P < 0.05). Spearman rank correlation analysis showed that ADC value before treatment and the reduced percentage of the maximum tumor diameter after 12 wk of treatment were negatively correlated, while the increase in the percentage of the ADC value 12 wk after treatment and the decrease in the percentage of the maximum tumor diameter were significantly positively correlated. The results of the ROC curve showed that ADC value with a chemotherapy ineffective threshold value of 1.14 × 10(-3) mm(2)/s before treatment had a sensitivity and specificity of 94.3% and 76.7%, respectively.
CONCLUSION: DWI ADC values can be used to predict the response of patients with liver metastasis of gastrointestinal tract cancer to chemotherapy with high sensitivity and relatively high specificity.

Entities:  

Keywords:  Chemotherapy; Gastrointestinal tract cancer; Liver metastatic tumor; Magnetic resonance imaging

Mesh:

Substances:

Year:  2016        PMID: 26973399      PMCID: PMC4779926          DOI: 10.3748/wjg.v22.i10.3031

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  33 in total

Review 1.  Lesion discrimination with breath-hold hepatic diffusion-weighted imaging: a meta-analysis.

Authors:  Zhi-Guang Chen; Li Xu; Si-Wei Zhang; Yan Huang; Rui-Huan Pan
Journal:  World J Gastroenterol       Date:  2015-02-07       Impact factor: 5.742

2.  The value of diffusion-weighted MRI to evaluate the response to radiochemotherapy for cervical cancer.

Authors:  Fei Kuang; Ziping Yan; Jian Wang; Ziyuan Rao
Journal:  Magn Reson Imaging       Date:  2013-12-27       Impact factor: 2.546

Review 3.  Gall bladder carcinoma: Aggressive malignancy with protean loco-regional and distant spread.

Authors:  Amit Nandan Dhar Dwivedi; Shivi Jain; Ruhi Dixit
Journal:  World J Clin Cases       Date:  2015-03-16       Impact factor: 1.337

4.  [Incidence of non-metastatic liver lesions in tumor patients: consequences for chemotherapy and local ablative procedures].

Authors:  S Schüle; A Altendorf-Hofmann; Y Dittmar; F Rauchfuß; U Settmacher
Journal:  Chirurg       Date:  2014-09       Impact factor: 0.955

5.  Evaluation of therapeutic response to concurrent chemoradiotherapy in patients with cervical cancer using diffusion-weighted MR imaging.

Authors:  Hyun Su Kim; Chan Kyo Kim; Byung Kwan Park; Seung Jae Huh; Bohyun Kim
Journal:  J Magn Reson Imaging       Date:  2012-09-27       Impact factor: 4.813

6.  Investigation of the diffusion abnormality index as a new imaging biomarker for early assessment of brain tumor response to radiation therapy.

Authors:  Reza Farjam; Christina I Tsien; Felix Y Feng; Diana Gomez-Hassan; James A Hayman; Theodore S Lawrence; Yue Cao
Journal:  Neuro Oncol       Date:  2013-12-09       Impact factor: 12.300

7.  Choroidal and cutaneous metastasis from gastric adenocarcinoma.

Authors:  Shoichiro Kawai; Tsutomu Nishida; Yoshito Hayashi; Hisao Ezaki; Takuya Yamada; Shinichiro Shinzaki; Masanori Miyazaki; Kei Nakai; Takayuki Yakushijin; Kenji Watabe; Hideki Iijima; Masahiko Tsujii; Kohji Nishida; Tetsuo Takehara
Journal:  World J Gastroenterol       Date:  2013-03-07       Impact factor: 5.742

8.  Chemotherapy-induced focal hepatopathy in patients with gastrointestinal malignancy: gadoxetic acid--enhanced and diffusion-weighted MR imaging with clinical-pathologic correlation.

Authors:  Na Yeon Han; Beom Jin Park; Deuk Jae Sung; Min Ju Kim; Sung Bum Cho; Chang Hee Lee; Yun-Jin Jang; So Yeon Kim; Dong Sik Kim; Soon Ho Um; Nam Hee Won; Kyung Sook Yang
Journal:  Radiology       Date:  2014-01-16       Impact factor: 11.105

9.  A phase I study of capecitabine, irinotecan, celecoxib, and radiation as neoadjuvant therapy of patients with locally advanced rectal cancer.

Authors:  Imtiaz Malik; Farabi Hussein; David Bush; Munther Alqaisi; Pedro Bernal; Janet Byrd; Carlos Garberoglio
Journal:  Am J Clin Oncol       Date:  2010-06       Impact factor: 2.339

10.  Pre-treatment diffusion-weighted MR imaging for predicting tumor recurrence in uterine cervical cancer treated with concurrent chemoradiation: value of histogram analysis of apparent diffusion coefficients.

Authors:  Suk Hee Heo; Sang Soo Shin; Jin Woong Kim; Hyo Soon Lim; Yong Yeon Jeong; Woo Dae Kang; Seok Mo Kim; Heoung Keun Kang
Journal:  Korean J Radiol       Date:  2013-07-17       Impact factor: 3.500

View more
  6 in total

Review 1.  Imaging strategies in the management of gastric cancer: current role and future potential of MRI.

Authors:  Alicia S Borggreve; Lucas Goense; Hylke J F Brenkman; Stella Mook; Gert J Meijer; Frank J Wessels; Marcel Verheij; Edwin P M Jansen; Richard van Hillegersberg; Peter S N van Rossum; Jelle P Ruurda
Journal:  Br J Radiol       Date:  2019-03-05       Impact factor: 3.039

2.  mRNA Delivery of a Bispecific Single-Domain Antibody to Polarize Tumor-Associated Macrophages and Synergize Immunotherapy against Liver Malignancies.

Authors:  Ying Wang; Karthik Tiruthani; Sirui Li; Mengying Hu; Guojie Zhong; Yu Tang; Sourav Roy; Lillian Zhang; Jun Tan; Chengheng Liao; Rihe Liu
Journal:  Adv Mater       Date:  2021-05-04       Impact factor: 32.086

3.  A prospective randomized trial comparing microwave and radiofrequency ablation for the treatment of liver metastases using a dual ablation system ─ The Mira study.

Authors:  Thomas J Vogl; Yousef Jaraysa; Simon S Martin; Tatjana Gruber-Rouh; Rock H Savage; Nour-Eldin A Nour-Eldin; Amela Mehmedovic
Journal:  Eur J Radiol Open       Date:  2022-01-28

4.  Predictive Value of MRI with Serum Lectin-Reactive Alpha-Fetoprotein for Liver Cancer Recurrence after Percutaneous Radiofrequency Ablation.

Authors:  Guangfeng Zhang; Yongxing Yun; Chunming Lin; Huafeng Li
Journal:  Evid Based Complement Alternat Med       Date:  2022-07-19       Impact factor: 2.650

Review 5.  Diffusion weighted magnetic resonance imaging of liver: Principles, clinical applications and recent updates.

Authors:  Anuradha Shenoy-Bhangle; Vinit Baliyan; Hamed Kordbacheh; Alexander R Guimaraes; Avinash Kambadakone
Journal:  World J Hepatol       Date:  2017-09-18

6.  Diagnostic performance of apparent diffusion coefficient values for the differentiation of intrahepatic cholangiocarcinoma from gastrointestinal adenocarcinoma liver metastases.

Authors:  Temel Fatih Yilmaz; Mehmet Ali Gultekin; Hacı Mehmet Turk; Mehmet Besiroglu; Dilek Hacer Cesme; Melih Simsek; Alpay Alkan; Huseyin Toprak
Journal:  Radiol Oncol       Date:  2021-12-22       Impact factor: 2.991

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.